SIGA Technologies (NASDAQ:SIGA) Stock Price Down 8.1%

SIGA Technologies, Inc. (NASDAQ:SIGA) traded down 8.1% during mid-day trading on Tuesday . The company traded as low as $9.37 and last traded at $9.59. 705,139 shares traded hands during trading, a decline of 26% from the average session volume of 949,103 shares. The stock had previously closed at $10.44.

SIGA Technologies Stock Performance

The business’s fifty day moving average price is $8.55 and its 200-day moving average price is $7.75. The stock has a market cap of $635.13 million, a PE ratio of 8.87 and a beta of 0.94.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings results on Thursday, August 1st. The company reported $0.03 earnings per share (EPS) for the quarter. The firm had revenue of $21.81 million for the quarter. SIGA Technologies had a net margin of 48.55% and a return on equity of 51.40%. During the same period in the previous year, the business earned ($0.04) EPS. Analysts forecast that SIGA Technologies, Inc. will post 1.01 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SIGA Technologies

A number of institutional investors and hedge funds have recently made changes to their positions in SIGA. DekaBank Deutsche Girozentrale bought a new stake in SIGA Technologies during the 2nd quarter worth approximately $40,000. Tower Research Capital LLC TRC raised its stake in SIGA Technologies by 200.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,955 shares of the company’s stock worth $45,000 after acquiring an additional 5,309 shares during the period. Steward Partners Investment Solutions LLC bought a new stake in SIGA Technologies during the 4th quarter worth approximately $58,000. Bayesian Capital Management LP bought a new stake in SIGA Technologies during the 1st quarter worth approximately $97,000. Finally, AQR Capital Management LLC bought a new stake in shares of SIGA Technologies during the second quarter valued at approximately $99,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.